Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses
Author(s)
Wallrapp, Antonia; Burkett, Patrick R.; Riesenfeld, Samantha J.; Kim, Se-Jin; Christian, Elena; Abdulnour, Raja-Elie E.; Thakore, Pratiksha I.; Schnell, Alexandra; Lambden, Conner; Herbst, Rebecca H.; Khan, Pavana; Tsujikawa, Kazutake; Xavier, Ramnik J.; Chiu, Isaac M.; Levy, Bruce D.; Regev, Aviv; Kuchroo, Vijay K.; ... Show more Show less
DownloadAccepted version (29.92Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo. CGRP induced marked changes in ILC2 expression programs in vivo and in vitro, attenuating alarmin-driven proliferative and effector responses. A distinct subset of ILCs scored highly for a CGRP-specific gene signature after in vivo alarmin stimulation, suggesting CGRP regulated this response. Finally, we observed increased ILC2 proliferation and type 2 cytokine production as well as exaggerated responses to alarmins in mice lacking the CGRP receptor. Together, these data indicate that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.
Date issued
2019-10Department
Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
Immunity
Publisher
Elsevier BV
Citation
Wallrapp, Antonia et al. "Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses." Immunity 51, 4 (October 2019): P709-723.e6 © 2019 Elsevier Inc
Version: Author's final manuscript
ISSN
1074-7613